Menu
05/04/2006
Drugs trial 'followed correct protocols'
An investigation into the drugs trial which left six men seriously ill in hospital has ruled that the trial followed the agreed protocol.
The Medicines and Healthcare Products Regulatory Agency report said that there was nothing in the way the trial was run which contributed to the adverse reactions suffered by the volunteers.
The report also found that there was no problem with the manufacturing of the drug TGN 1412, that it did not appear to have been contaminated and that the men all received the correct dose.
The conclusions were published in the MHRA's interim report. MHRA Chief Executive Professor Kent Woods said: "There are still further tests planned and until these are complete we cannot be firm about our conclusions. However, if these findings were to be confirmed, it would indicate that this product showed a pharmacological effect in man which was not seen in pre-clinical tests in animals at much higher doses."
Professor Woods said that Health Secretary Patricia Hewitt had agreed to establish a group of international experts to examine the issue further.
The six men all fell ill after taking TGN 1412 - an anti-inflammatory designed to treat rheumatoid arthritis, leukaemia and multiple sclerosis - during a trial at Northwick Park Hospital, London.
The men suffered multiple organ failure and two were left in a critical condition. However, five of the men have now been released from hospital, while the remaining patient is said to be making "steady progress".
The trial, which was being conducted by US firm Parexel on behalf of German drug manufacturers TeGenero, was immediately suspended when the men fell ill.
(KMcA/GB)
The Medicines and Healthcare Products Regulatory Agency report said that there was nothing in the way the trial was run which contributed to the adverse reactions suffered by the volunteers.
The report also found that there was no problem with the manufacturing of the drug TGN 1412, that it did not appear to have been contaminated and that the men all received the correct dose.
The conclusions were published in the MHRA's interim report. MHRA Chief Executive Professor Kent Woods said: "There are still further tests planned and until these are complete we cannot be firm about our conclusions. However, if these findings were to be confirmed, it would indicate that this product showed a pharmacological effect in man which was not seen in pre-clinical tests in animals at much higher doses."
Professor Woods said that Health Secretary Patricia Hewitt had agreed to establish a group of international experts to examine the issue further.
The six men all fell ill after taking TGN 1412 - an anti-inflammatory designed to treat rheumatoid arthritis, leukaemia and multiple sclerosis - during a trial at Northwick Park Hospital, London.
The men suffered multiple organ failure and two were left in a critical condition. However, five of the men have now been released from hospital, while the remaining patient is said to be making "steady progress".
The trial, which was being conducted by US firm Parexel on behalf of German drug manufacturers TeGenero, was immediately suspended when the men fell ill.
(KMcA/GB)
Related UK National News Stories
Click here for the latest headlines.
08 October 2010
Double Jeopardy Reforms Commence
A Bill to reform the centuries-old law which prevents a person being tried twice for the same offence in Scotland has been introduced. The 'double jeopardy' principle dates back over 800 years, but questions have been raised in recent years about whether the law now needs to be updated for the 21st Century.
Double Jeopardy Reforms Commence
A Bill to reform the centuries-old law which prevents a person being tried twice for the same offence in Scotland has been introduced. The 'double jeopardy' principle dates back over 800 years, but questions have been raised in recent years about whether the law now needs to be updated for the 21st Century.
28 March 2006
Drug trial pair released from hospital
Two of the six men who were hospitalised after a drugs trial went wrong have been allowed to return home. Doctors at Northwick Park Hospital said that the two men had responded "very well" to treatment and had made an "excellent recovery". However, four men remain in hospital.
Drug trial pair released from hospital
Two of the six men who were hospitalised after a drugs trial went wrong have been allowed to return home. Doctors at Northwick Park Hospital said that the two men had responded "very well" to treatment and had made an "excellent recovery". However, four men remain in hospital.
20 March 2006
Company admits trial drug caused side effects in monkeys
The drug which has left six men seriously ill in hospital during a trial caused glands in two monkeys to swell during earlier tests, it has been revealed. However, TeGenero, the German company that manufactured the TGN1412 drug, said that the symptoms shown by the monkeys differed from those suffered by the men during the trial last week.
Company admits trial drug caused side effects in monkeys
The drug which has left six men seriously ill in hospital during a trial caused glands in two monkeys to swell during earlier tests, it has been revealed. However, TeGenero, the German company that manufactured the TGN1412 drug, said that the symptoms shown by the monkeys differed from those suffered by the men during the trial last week.
22 September 2008
Cancer Patient Dies After Medical Trial
A cancer patient has died after being given an overdose during a drugs trial at the university College London Hospital (UCLH), an inquest has heard. Gary Foster, 27, was repeatedly given twice the amount of chemotherapy drugs he should have been prescribed, the hospital said.
Cancer Patient Dies After Medical Trial
A cancer patient has died after being given an overdose during a drugs trial at the university College London Hospital (UCLH), an inquest has heard. Gary Foster, 27, was repeatedly given twice the amount of chemotherapy drugs he should have been prescribed, the hospital said.
22 October 2012
Birmingham Men On Trial For 'Mass Suicide' Terrorist Plot
Three Birmingham men have gone on trial accused of planning a bomb campaign which, prosecutors say, may have been bigger than the 7 July London attacks.
Birmingham Men On Trial For 'Mass Suicide' Terrorist Plot
Three Birmingham men have gone on trial accused of planning a bomb campaign which, prosecutors say, may have been bigger than the 7 July London attacks.
-
Northern Ireland WeatherThis Evening and Tonight:Showers, scattered in the evening, will clear by midnight leaving the night dry with clear spells. Perhaps a touch of ground frost. Cloud will spread east towards morning. Minimum temperature 2 °C.
